Skeletal Muscle Adaptation in Response to Supervised Exercise Training for Intermittent Claudication  by Beckitt, T.A. et al.
at SciVerse ScienceDirect
European Journal of Vascular and Endovascular Surgery 44 (2012) 313e317Contents lists availableEuropean Journal of Vascular and Endovascular Surgery
journal homepage: www.ejves.comSkeletal Muscle Adaptation in Response to Supervised Exercise Training for
Intermittent Claudication
T.A. Beckitt*, J. Day, M. Morgan, P.M. Lamont
Department of Vascular Surgery, Bristol Royal Inﬁrmary, UK
WHAT THIS PAPER ADDS
 This is the ﬁrst study in which myosin protein expression has been been used, as apposed to immunohistochemistry, to seek
evidence of skeletal muscle adaptation in response to supervised exercise training for claudication.a r t i c l e i n f o
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Objectives: There is evidence that the improvement following supervised exercise for claudication results
from skeletal muscle adaptation. The myosin heavy chain (MHC) determines muscle ﬁbre type and
therefore efﬁciency. Immunohistochemical analysis has failed to take account of hybrid MHC expression
within myoﬁbres. This study sought evidence of differential MHC protein expression following super-
vised exercise for claudication.
Design: 38 claudicants were recruited. Subjects undertook a three-month supervised exercise pro-
gramme. Controls were patients awaiting angioplasty for claudication.
Materials and methods: Subjects underwent paired gastrocnemius biopsy. Relative expression of MHC
proteins was determined by SDS-PAGE electrophoresis. Non-parametric data is presented as median with
the inter-quartile range and parametric as the mean  standard deviation.
Results: Upon completion of the exercise programme there was a 94% increase (124 (106e145) to 241
(193e265) metres, p ¼ 0.002) in maximumwalking distance, which was not evident in the control group.
An 11.1% (p ¼ 0.02) increase in MHC I expression was observed in the exercise but not the control group
(34.3%  6.8 to 45.4%  4.4). There was a positive correlation between the change in MHC I expression
and the improvement in claudication distance (r ¼ 0.69, p < 0.05).
Conclusions: Supervised exercise training for claudication results in an increase in the proportion of MHC
type I expression within the symptomatic gastrocnemius muscle.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Intermittent claudication is a common problem in an ageing
population, with some reports that 20% of the over 75’s are
affected.1 There has been little change in the treatment of claudi-
cation since the advent of endoluminal angioplasty in 1964.2
Interventional treatments for claudication are not without risk
and in addition there are concerns about the longevity of beneﬁtof Vascular Surgery, Bristol
itt).
ciety for Vascular Surgery. Publishefollowing endovascular therapy.3,4 Whilst all patients should have
their risk factors addressed in view of the associated cardiovascular
mortality and morbidity,5 pharmacological agents have only been
shown to produce modest beneﬁts when treating symptoms of
claudication.6 The mainstay of treatment for intermittent claudi-
cation has therefore been risk factor control and exercise.7 Super-
vised exercise training has been shown to have signiﬁcant
symptomatic beneﬁts in claudication producing a 108% in treadmill
assessed pain free walking,8,9 but in view of the signiﬁcant co-
morbidity associated with claudication5 not all patients are able
to participate and there remains poor provision in the UK.10
The mechanisms for this symptomatic improvement witnessed
as a result of exercise training remain unclear. There is nod by Elsevier Ltd. All rights reserved.
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exercise induces the development of collateral blood vessels,
resulting in enhanced whole limb blood ﬂow9 and whilst it has
been hypothesised that exercise training may result in re-
distribution of blood ﬂow within the symptomatic limb, there is
only one study to support this, with no corroborating data pub-
lished since 1969.11
The observation that haemodynamic improvements following
re-vascularisation12 are not accompanied by a comparable func-
tional improvement has led to the concept that in addition to the
limitation of blood ﬂow resulting in claudication, there may also be
an acquired metabolic defect or “metabolic myopathy”.13 It has
been hypothesised that supervised exercise training may reverse
this metabolic myopathy, a hypothesis which is supported14 by
reports of reduced accumulation of the mitochondrial buffers, the
acyl-carnitines, as a result of supervised exercise training.
One of the key determinants of skeletal muscle metabolism is
the myosin heavy chain (MHC) of which three isoforms are
expressed inmature skeletal muscle; MHC I, IIa and IIb. Slow twitch
muscle ﬁbres (type I) are composed of MHC I and are coupled to
efﬁcient oxidativemetabolism. In contrast, fast twitchmuscle ﬁbres
composed of MHC IIb are glycolytic and rapidly switch to anaerobic
metabolism under stress resulting in the accumulation of lactate.
An increase in the proportion of MHC type I is potentially
beneﬁcial for claudicants, increasing oxidative capacity and
reducing the rapid switch to anaerobic glycolysis associated with
the faster glycolytic ﬁbres (MHC IIb).
Immunohistochemistry has been used to seek evidence of
skeletal muscle adaptation resulting from a 6-week programme of
exercise training in claudicants14 and no change in the type I ﬁbre
area was observed. It has however since become apparent that
muscle ﬁbres are actually hybrids expressing more than one
myosin heavy chain along their length and this diversity is more
prominent in ageing skeletal muscle.15 As a result, traditional
mATPase immunohistochemistry may underestimate any potential
muscle adaptation. One small study in patients with heart failure
using SDS-PAGE electrophoresis to determine MHC protein
expression has reported a signiﬁcant 12.6% increase in MHC I
expression in response to a supervised resistance cycling training
programme.16
Methods
The initial study design of a randomised control trial was
refused by the regional research ethics committee, who deter-
mined that it was unethical given the evidence for its effectivity not
to offer all claudicants supervised exercise training. Ethical
approval was therefore obtained for a non-randomised study in
which patients awaiting angioplasty for claudicationwere recruited
to the control group.
Using Keteyians’ data in which SDS-PAGE electrophoresis was
used to study patients with heart failure, a power calculation was
undertaken. A sample size of 26 paired biopsies would have a 90%
power to detect a 10% difference in means at the p ¼ 0.05 signiﬁ-
cance level.
Thirty-eight subjects with stable claudication were recruited
from vascular outpatient clinics at the Bristol Royal Inﬁrmary and
informed consent was obtained. Twenty-seven subjects were
recruited to a 12-week supervised exercise programme for claudi-
cation. Paired Bergstrom needle skeletal muscle biopsies were
taken from the symptomatic gastrocnemius muscle at recruitment
and upon completion of the study. A further 11 subjects with
symptomatic calf claudication, whowere awaiting endovascular re-
vascularisation, were recruited to a control group and paired
skeletal muscle biopsies were also taken at recruitment andfollowing a period of exercise advice, prior to re-vascularisation.
The controls were matched as closely to the exercise group as
possible for age, sex, ABPI, walking distance, and the distribution of
disease. The control group were advised to exercise at least three
times weekly for a minimum of 30 min, walking to the point at
which claudication becomes intolerable.
All subjects had at least a six-month history of stable symp-
tomatic calf muscle claudication, which was induced on treadmill
testing at 2.5 kph and 10 of incline.
Patients who had previously had endovascular or surgical
intervention or who had attended a supervised exercise pro-
gramme for claudication were excluded. All subjects were already
receiving an anti-platelet agent and a statin and subjects treated
with a phosphodiesterase inhibitor for claudication were excluded.
All subjects underwent an arterial duplex to document the
distribution of disease prior to recruitment and subjects with iso-
lated iliac disease suitable for angioplasty or an ankle-brachial
pressure index of greater than 0.9 were excluded from the study.
In view of the need for skeletal muscle biopsy subjects with
evidence of critical ischaemia manifest by rest pain or tissue loss
and subjects on oral anti-coagulants were excluded from the study.
Exercise regime
A twelve-week supervised exercise-training programme was
utilised. The exercise classes were established in 2001 and a rand-
omised control trial has previously demonstrated this regime to be
effective.17 The training exercises, delivered in a circuit format,
were targeted at the calf muscles. Following a 10 min warm up of
passive stretching exercises, each of the ﬁve exercise stations was
undertaken for 8 min. The exercises were designed to require little
or no specialist equipment such that patients could continue the
programme in their own home and treadmill exercise was delib-
erately excluded in order to prevent familiarisation bias. The
exercises comprised; step ups, toe walking, heel raises, wobble
board and resistance cycling. As exercise to claudication has been
identiﬁed as a key factor in success, patients are encouraged to
exercise to the point of claudication.9
Treadmill assessment
Subjects’ maximum walking distance (MWD) and claudication
distance (CD) were recorded using a ﬁxed ramped treadmill
assessment at 2.5 km/kph at a 10% incline, as this proved tolerable
and reproduced claudication symptoms in the majority of patients.
All subjects underwent treadmill assessment at recruitment and
upon completion of the study. The tests were undertaken on the
same Trimline 4000 treadmill. The display was shielded from the
patients view, such that the time and distances walked could be
kept from the patient in order to prevent bias.
Muscle biopsy
Biopsies were taken at a separate appointment from the
treadmill testing. Subjects were brought to the department by car
or taxi and biopsies taken after a 30-min period of rest in order to
prevent any confounding effects of acute exercise. Biopsies were
taken with a modiﬁed Bergstrom needle technique.18 Following
injection of between 2 and 5 ml of plain 2% lidocaine, the skin and
muscle fascia were incised through a horizontal stab incision. The
subsequent biopsy was taken 15mm adjacent to the ﬁrst in order to
minimise differences resulting from muscle heterogeneity, but in
order to be sufﬁciently separated to prevent biopsying scar tissue.
The specimens were labelled with a sequentially allocated patient
number which did not elucidate in which arm of the study the
Table 1
Group demographics at recruitment.
Exercise group Angioplasty group
n ¼ 27 n ¼ 11
Age
Mean  SD 67.6  6.1 68.3  5.8**
years
Sex M:F 20:7 8:3*
ABPI
median (IQR)
0.66 (0.55e0.79) 0.68 (0.54e0.82)*
Current Smoker 9 (33%) 3 (27%)*
Diabetes 10 (37%) 4 (36%)*
MWD metres 124 (106e145) 137 (103e161)*
At recruitment there were no signiﬁcant differences in the age, resting ankle
brachial pressure indices or the treadmill-assessed maximum walking distances
between the two groups. *p > 0.50 **p > 0.20.
T.A. Beckitt et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 313e317 315subject was involved and were then snap frozen in isopentane
cooled by liquid nitrogen and stored at80 c for subsequent batch
homogenization. Sample analysis was not truly blinded as patient
recruitment, treadmill visits, muscle biopsy and sample processing
were all undertaken by the lead investigator.
Sample processing
Samples were subsequently defrosted and mechanically
homogenized in lysis buffer (containing 10 mM Tris HCl, 5 mM
EDTA, 30 mM NaCL. 50 mM NaF, 100 mM sodium orthovanadate, 1%
Triton X-100, 01 mM PMSF, phosphatase inhibitor (sigma P5726)
and protease inhibitor cocktails (sigma eP8340)). The samples
were then centrifuged for 15 min at 4 c at 1000g. Following
centrifugation the supernatant protein concentration was deter-
mined by bicinchoninic acid (BCA) assay and 50 mg of protein per
well was suspended in sample buffer and loaded onto the poly-
acrylamide gels in duplicate. 8% resolving gels were used19,20 and
the gels were run in a cold room overnight at 16mA. The position of
the protein bands was conﬁrmed against 20 mL of Biorad colour
marker RPN 756V. In view of the difﬁculties of reliably transferring
such a large protein to a membrane for Western blotting, quanti-
ﬁcation of the three MHC bands was achieved on gel by optical
density analysis following silver-staining Fig. 1, as had been
described by Keteyian.16 The relative expression of the three MHC
isoforms could then be determined as a proportion of the total
optical density.
Data analysis
The relative proportions of MHC I, IIa and IIb are expressed as
percentages of the total. Statistical analysis using SPSS, compari-
sons made between groups for normally distributed variables by
independent samples t testing and within groups by paired sample
t testing. Non-parametric comparisons between groups by Mann
Whitney U test and within groups by Wilcoxon signed rank. Non-
parametric data is presented as median with the (interquartile
range) and parametric as the mean  the standard deviation.
Results
The demographic data for the study and control groups is pre-
sented in Table 1. At recruitment there was no signiﬁcant difference
in age, sex, resting ankle brachial pressure, smoking status, co-
morbidity or treadmill assessed maximum walking distances
between the two groups. The distribution of disease was similar
between the two groups (Table 2) with predominantly superﬁcialFigure 1. A digital scan of a silver stained 8% resolving gel demonstrating the three
myosin heavy chain bands. This gel shows paired pre and post intervention muscle
biopsies from a subject in the exercise group.femoral artery disease in both, it should be noted however that
there were 3 patients in the exercise but not the angioplasty group
with common femoral artery stenoses. Upon completion of the
supervised exercise programme a signiﬁcant 94% increase was
witnessed in the maximum walking distance (241 (193e265)
metres, p < 0.05). No such improvements were witnessed in the
control group following the period of exercise advice (131
(114e152) metres, p > 0.20).
The relative expression of the myosin heavy chains is shown in
Table 3.
A signiﬁcant 11.1% (p ¼ 0.02) increase in the proportion of slow
oxidative MHC I expression was observed upon completion of the
supervised exercise programme, which did not occur in the control
group. This was accompanied by corresponding reductions in the
proportion of MHC IIa and IIb, although neither reached indepen-
dent signiﬁcance. Similarly there was no signiﬁcant correlation
between the level of MHC I expression and the treadmill assessed
walking distances (r ¼ 0.58 p > 0.1). There was however, a signiﬁ-
cant positive correlation between the subjects’ percentage increase
in claudication distance and the change in MHC I expression upon
completion of the supervised exercise-training programme
(r ¼ 0.69 p < 0.05). When the data is analysed by dividing the
subjects into quartiles based upon their percentage change in MHC
I expression, (Table 4) it can be seen that upon completion of the
supervised exercise programme those subjects in whom the
greatest increment in MHC I expression was witnessed were also
those in whom the greatest increases in both claudication and
maximum walking distances were witnessed.
In view of previous data16 suggesting a differential response in
MHC expression between the sexes, comparisons were made
between the men and women in the exercise study (Table 5). The
majority of subjects recruited to the study were male (20:7). There
was no signiﬁcant difference in the proportion of MHC type I
expression at recruitment when compared between men and
women (p ¼ 0.60). On completion of the exercise programmeTable 2
Anatomical distribution of arterial disease at recruitment.
Duplex detected disease Exercise group Angioplasty group
n ¼ 27 n ¼ 11
Iliac 3 3
Common femoral 3 0
Superﬁcial femoral 21 10
Popliteal 6 1
Crural 2 0
Disease at more than one level 8 3
Table 3
Myosin heavy chain expression by group.
Proportion of MHC expression % MHC I % MHC IIa % MHC IIb
Exercise group Recruitment 34.3  6.8 42.0  7.1 23.7  4.7
Completion 45.4  4.4* 36.7  4.9 17.9  4.2
Angioplasty group Recruitment 36.1  5.9 41.1  5.1 23.8  4.1
Completion 37.4  5.7 38.7  5.1 23.9  5.1
Proportion ofMyosin heavy chain I, IIa and IIb expression as a percentage of the total
for each biopsy. There was a signiﬁcant increase in the proportion of MHC I
expression in the exercise group. *p ¼ 0.02.
Table 5
Gender differences in myosin heavy chain expression within the exercise group.
Exercise Group Men n ¼ 20 Women n ¼ 7
Recruitment Completion Recruitment Completion
% MHC I 33.9  6.8 46.9  5.9* 35.2  4.8 44.2  3.9*
% MHC IIa 42.5  6.1 37.2  4.6 39.7  7.3 34.1  5.1
% MHC IIb 23.6  4.6 16.9  4.9 25.1  4.9 21.7  3.6
Subgroup analysis of myosin heavy chain expression by sex, revealed that following
supervised exercise there was signiﬁcant increase in the proportion of MHC I for
both men and women. *p < 0.05.
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men and women (13% and 9% respectively).
Discussion
This study has demonstrated that supervised exercise training
in claudicants is associated with a signiﬁcant increase in the
proportion of slow oxidative myosin heavy chain type I expres-
sion within the symptomatic gastrocnemius muscle. Increases in
the slow oxidative MHC I are potentially beneﬁcial for claudi-
cants, by increasing oxidative capacity and reducing the rapid
switch to anaerobic glycolysis associated with faster glycolytic
ﬁbres, thereby reducing the painful accumulation of lactate.
There is in addition evidence using both whole body calorimetry
and 31P-MRS21,22 that an increase in type I muscle ﬁbres and
a reduction in type IIb ﬁbres is associated with increased meta-
bolic economy.
This data contradicts a previous report in which immunohisto-
chemistry was used to determine muscle ﬁbre type.14 In his small
study Hiatt reported that a twelve-week treadmill based super-
vised exercise programme was associated with both improved
treadmill assessed walking distances and increased peak oxygen
consumption, beneﬁts that were not witnessed as a result of
strength training. However, when gastrocnemius biopsies were
taken from these 10 subjects, despite the signiﬁcant symptomatic
improvement, the proportion of type I myoﬁbres in the symp-
tomatic limb, determined by area, was unchanged. This apparent
discrepancy is likely to result from the use of mATPase immuno-
histochemistry, given the evidence that muscle ﬁbres are actually
hybrids, expressing more than one myosin heavy chain isoform
along their length and that the proportion of hybrid ﬁbres is
increased both by exercise and age.15,23 It is likely therefore, that
Hiatt’s results reﬂect a tendency of traditional mATPase immuno-
histochemistry, used for ﬁbre typing, to underestimate the degree
of myosin heavy chain adaptation.
One previous report has used a combination of both mATPase
immunohistochemistry and MHC electrophoresis to seek evidence
of skeletal muscle adaptation in response to progressive resistanceTable 4
Percentage changes in MHC I expression and treadmill walking distances upon










MHC I n¼ Median Range n¼ Median Range
þ 0e4% 3 53% (38e76) 2 68% (54e82)
þ 4e8% 5 77% (65e103) 5 89% (61e112)
þ 8e12% 12 109% (47e171) 14 114% (34e163)
þ 12e16% 7 163%* (131e322) 6 156%* (117e241)
A table comparing the percentage increase in treadmill assessed walking distances
upon completion of the exercise trial with the increase in MHC I expression divided
into four quartiles. *p < 0.05 Kruskal Wallis.training in claudicants.24 In contrast to previous data14 McGuigan
reported that progressive strength training could produce signiﬁ-
cant improvements inwalking performance. He observed increases
in the overall type I and type II muscle ﬁbre areas, as determined by
mATPase immunohistochemistry. In addition McGuigan found that
strength training was associated with a reduction in MHC IIb
expression measured by SDS-PAGE electrophoresis.
McGuigan found no signiﬁcant change in the percentage of MHC
I or MHC IIA. Given that the relative proportion of type I ﬁbres has
been shown to correlatewith exercise performance in patients with
peripheral vascular disease,25 these ﬁndings are surprising.
However the apparent discrepancy is likely to result from the
speciﬁc form of progressive resistance training used. Certainly in
healthy individuals the differential effects of strength versus
aerobic exercise training are well reported.26
In this study, there was no correlation between the absolute
proportion of MHC I expression and treadmill assessed walking
performance, a ﬁnding which contradicts data published by Askew
in 2005.25 There was however a signiﬁcant positive correlation
between the percentage increase in MHC I expression and the
subjects improvement in their treadmill assessed claudication
distance (r ¼ 0.69, p < 0.05).
One previous report of exercise training in heart failure patients
has suggested that there may be sex differences in the responses of
skeletal muscle to exercise training.16 In this study there was also
a male predominance (20 men, 7 women), however when both
recruitment myosin heavy chain expression and the exercise
responsewere compared, therewas no difference between themen
and women, with increases in the proportion of type I myosin
heavy chain of þ13% and þ9% respectively. Keteyians’ study was
clearly ﬂawed as a result of; the small sample size, absence of
a control group and the variability of any particular subjects
duration of training (14e24 weeks). Nevertheless, one alternative
explanation for this difference is that exercise training in the
presence of claudication may be a more potent stimulus for local
skeletal muscle adaptation than exercise training in the presence
of heart failure. Certainly models, in which unilateral exercise has
been undertaken in the presence of ischaemia, have shown that it
is a more potent stimulus of growth factor expression.27
The plasticity of human skeletal muscle in response to exercise
training has been extensively studied in health and the observation
that endurance athletes have a predominance of MHC Ia as
compared to the predominance of MHC IIa/IIx seen in sprinters28 is
evidence that differing exercise regimes can have quite different
effects upon muscle structure. There must therefore be differing
signalling pathways for muscle hypertrophy in response to resis-
tance training and muscle metabolic adaptation in response to
endurance training. The mammalian Target of Rapamycin (MTor),
a member of the phosphatidylinositol kinase family, appears to be
responsible for the muscle hypertrophy seen following strength
training,29 whereas muscle metabolic adaptation appears to be
partly an activity dependent phenomenon in which calcium inﬂux
is responsible for activation of the calcineurin-NFAt pathway
(nuclear factor of activated T cells). This has been shown amongst
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isoform.30There is also evidence that local hypoxia is a potent
stimulus to skeletal muscle adaptation. It is known that the greatest
improvements in walking distances are associated with exercise
beyond subject’s claudication distance and there is certainly good
evidence that it is a potent activator of growth factor expression.27
In addition the greatest improvements in walking distances are
associated with exercise beyond subject’s claudication distance and
hypoxia may be the most potent stimulus in claudication. Hypoxic
ischaemic factor (HIF) is a key signalling mechanism, which has
been linked to increased vascular endothelial growth factor (VEGF)
and Peroxisome proliferator-activated receptor-g coactivator (PGC-
1a) expression. HIF is post transcriptionally regulated, being stable
in hypoxic conditions and stable analogues of HIF may therefore
offer therapeutic applications. There is certainly evidence that
single bouts of exercise are associated with increased vascular
endothelial growth factor expression31 and these may be main-
tained following several weeks of exercise training.
The authors accept the limitations associated with an unblinded
and non-randomised study. This may introduce bias particularly
with regard to any difference in the distribution of disease between
the exercise and control group. There were however no differences
in MHC expression between the two groups at recruitment in this
study. Whilst progressive changes in MHC expression have previ-
ously been described in patients with deteriorating peripheral
arterial disease, these changes were limited to subjects with critical
ischaemia and as such are unlikely to have had any bearing upon
the results of this study.
This study has demonstrated that a circuit-based programme of
non-treadmill exercises is an effective symptomatic treatment for
claudication producing signiﬁcant improvements in walking
distances. In addition it is the ﬁrst report in which supervised
exercise training for claudication has been shown to increase the
relative expression of slow oxidative myosin heavy chain type I.
Whilst it has been reported that some of the beneﬁts witnessed
following exercise for claudication are systemic,31 this ﬁbre type
adaptation resulting in enhanced metabolic economy, suggests that
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